Support WBURAnalysisLots of drug companies talk about putting patients first — but this one actually didPlay07:32Download AudioJon HamiltonMay 15, 2024 ShareIn college, Amylyx cofounders Josh Cohen and Justin Klee dreamed of finding a treatment for diseases like ALS. When their drug's promise did not pan out, they pulled it voluntarily from the market. (Amylyx Pharmaceuticals)
